Skip to content
HowShorted

OPKO Health, Inc. short interest in 2024

In 2024, OPKO Health, Inc.'s disclosed short interest ran from 13.93% of shares outstanding on 31 Jan 2024 to 13.38% on 31 Dec 2024, a change of -0.55 percentage points. The year's high was 14.66% on 15 Mar 2024 and its low 11.19% on 15 Apr 2024, averaging 13.23% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 38.17 days on 15 Oct 2024. Full history: OPKO Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for OPKO Health, Inc. in 2024

2024 in figures

Start of year
13.93% (31 Jan 2024)
End of year
13.38% (31 Dec 2024)
Change
-0.55 pp
High
14.66% (15 Mar 2024)
Low
11.19% (15 Apr 2024)
Average
13.23%
Highest days to cover
38.17 (15 Oct 2024)
SEC filings marked
8

Every report in 2024

OPKO Health, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
31 Jan 202413.93%12.38
15 Feb 202414.05%14.88
29 Feb 202414.21%10.96results (8-K)
15 Mar 202414.66%11.3910-K filed
28 Mar 202413.43%5.36
15 Apr 202411.19%9.23
30 Apr 202412.42%23.15
15 May 202412.23%22.0710-Q filed, results (8-K)
31 May 202412.44%24.49
14 Jun 202412.55%23.76
28 Jun 202412.10%23.36
15 Jul 202411.99%34.75
31 Jul 202412.53%23.86
15 Aug 202413.00%28.6510-Q filed, results (8-K)
30 Aug 202413.98%33.28
13 Sep 202414.09%32.82
30 Sep 202414.11%23.17
15 Oct 202413.33%38.17
31 Oct 202413.75%33.01
15 Nov 202414.01%19.6810-Q filed, results (8-K)
29 Nov 202414.44%21.55
13 Dec 202412.43%17.28
31 Dec 202413.38%25.85

See also: OPKO Health, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.